Member Info for havegun

bought into this company in 2015 for a similar price it is now and saw it rise into the twenties although the charts on here do not show that.It fell back and I sold around 8p.This company is in a far better position now after its teething troubles and am relaxed with its future now.So I am back in.

RNS this is going to big I reckon.

Think dumbass meant to say seven pounds.

on Tosh.

is the 5p idiot

jubbly at these bargain prices.

Makes you wonder if we are going to ever relist after all these years of waiting.I sincerely hope so and for it to have made it all worth while.

hold up of listings as gone on now far too long.

List or not to list.That is the question.

CompanyEPIC/TIDMSEDOL/ISIN Share Tweet Print RSS Flying Brands Ltd (FBDU) Flying Brands Ltd Final Results RNS Number : 6281M Flying Brands Limited 30 April 2018 Flying Brands Limited ("Flying Brands" or the "Company") Final Audited Results Flying Brands announces today its audited financial results for the year ended 31 December 2017. For further information, please contact: Flying Brands Limited 0207 469 0930 Trevor Brown Peterhouse Corporate Finance Limited 0207 220 9797 Lucy Williams/ Heena Karani Chief Executive's Statement It is with pleasure that I present the annual financial statements to shareholders for the year ended 31 December 2017. This year has been one of transition and we have made considerable progress in implementing our plans: � In June 2017, we raised �550,000, completed the acquisition of Stone Checker Software� Ltd ("Stone Checker") and the Company was readmitted to trading on the standard segment of the Main Market; � In October 2017, we announced that the prototype testing and evaluation by the StoneChecker team of its StoneChecker� Kidney Stone analysis software ("StoneChecker Software") had been successfully completed; and � In December 2017, StoneChecker announced that it had affixed a CE mark to 'StoneChecker', thereby confirming that the software now meets the requirements of the Medical Device Directive (MDD-93/42EEC) and satisfies the quality, safety and performance standards for medical devices in the European Union (EU), paving the way for the commercial application of StoneChecker Software. Outlook Post the year-end, the Company announced that Stone Checker signed an exclusive marketing and distribution agreement with Korea Computer Motion ISG, for sales and distribution of its StoneChecker Software. In addition, the Company acquired Imaging Biometrics ("IB") a Wisconsin-based company advancing the field of medical imaging by specialising in the design and manufacture of advanced visualisation software solutions using quantitative imaging endpoints/biomarkers. IB are specialists in research, manufacturing and clinical evaluation of software products in radiology and have successfully developed products from the discovery phase through to full FDA regulatory approval. The acquisition of IB represents the first step in the execution of our vision to become a significant participant in the field of medical imaging diagnostics and the application of artificial intelligence in medical imaging. We look forward to the future with confidence and excitement. Trevor Brown Chief Executive Officer 27 April 2018 Principal activities The principal activity in the year ended 31 December 2017 is the provision of convenient, cost-effective and clinical treatment to patients based o

This share for a few days now and would have bought but no way with a spread like it is.

Share Tweet Print RSS Cradle Arc PLC (CRA) Cradle Arc PLC Option Agreement for a JV and/or Sale of Luiri RNS Number : 9462K Cradle Arc PLC 16 April 2018 Cradle Arc plc / EPIC: CRA.L / Market: AIM / Sector: Mining 16 April 2018 Cradle Arc plc ("Cradle Arc", the "Company" or, together with its subsidiaries, the "Group") Option Agreement for a Joint Venture and/or Sale of Luiri Gold Mines Limited Cradle Arc (AIM: CRA), the African focused base and precious metals exploration and production company, is pleased to announce that it has today entered into an option agreement (the "Agreement") pursuant to which it has granted Singa Holdings Zambia Private Limited ("Singa") an option to establish a joint venture and/or an option to acquire the entire issued share capital of Luiri Gold Mines Limited ("Luiri"), the Company's wholly owned subsidiary, which holds the Matala and Dunrobin gold assets in Zambia. Highlights: � Cradle Arc has granted Singa an exclusive option to acquire the entire issued share capital of Luiri for a total cash consideration of US$2.5 million (the "Share Option"), which expires on 1 July 2018, unless otherwise extended. � In the event the Share Option is exercised and with effect from completion of the acquisition of Luiri, Cradle Arc will receive a royalty of 1.5% of gross revenue generated from the Matala and Dunrobin gold assets, up to a maximum aggregate amount of the Net Present Value of US$2.5 million discounted at 8%. � Cradle Arc has also granted Singa an exclusive option which expires on 30 June 2018, unless otherwise extended, to form a joint venture for the operation of the Matala and Dunrobin gold assets (the "JV Option"). In the event the JV Option is exercised, any such joint venture terminates upon the commencement of commercial gold production. In the event that Singa elects to exercise the JV option, Cradle Arc has the right to require Singa to exercise the Share Option. � An option fee of US$30,000 (the "Option Fee") is payable by Singa to Cradle Arc in three equal monthly tranches, commencing on the date of the Agreement. Kevin van Wouw, CEO of Cradle Arc, said: "The development of our Zambian gold assets has long been an important goal for the Company. We are, however, extremely mindful of the potential dilution that raising equity funds for the development of Matala could have on existing shareholders at the Company's current share price, and we therefore consider that this partnership with Singa represents the best path towards potential production in the near to mid-term. "Should the Share Option be exercised, the total amount payable to Cradle Arc would, in our view, represent fair value given the project's current stage of development and will support the Company's future strategy. On

wrong board.

Share Tweet Print RSS Cradle Arc PLC (CRA) Cradle Arc PLC Option Agreement for a JV and/or Sale of Luiri RNS Number : 9462K Cradle Arc PLC 16 April 2018 Cradle Arc plc / EPIC: CRA.L / Market: AIM / Sector: Mining 16 April 2018 Cradle Arc plc ("Cradle Arc", the "Company" or, together with its subsidiaries, the "Group") Option Agreement for a Joint Venture and/or Sale of Luiri Gold Mines Limited Cradle Arc (AIM: CRA), the African focused base and precious metals exploration and production company, is pleased to announce that it has today entered into an option agreement (the "Agreement") pursuant to which it has granted Singa Holdings Zambia Private Limited ("Singa") an option to establish a joint venture and/or an option to acquire the entire issued share capital of Luiri Gold Mines Limited ("Luiri"), the Company's wholly owned subsidiary, which holds the Matala and Dunrobin gold assets in Zambia. Highlights: � Cradle Arc has granted Singa an exclusive option to acquire the entire issued share capital of Luiri for a total cash consideration of US$2.5 million (the "Share Option"), which expires on 1 July 2018, unless otherwise extended. � In the event the Share Option is exercised and with effect from completion of the acquisition of Luiri, Cradle Arc will receive a royalty of 1.5% of gross revenue generated from the Matala and Dunrobin gold assets, up to a maximum aggregate amount of the Net Present Value of US$2.5 million discounted at 8%. � Cradle Arc has also granted Singa an exclusive option which expires on 30 June 2018, unless otherwise extended, to form a joint venture for the operation of the Matala and Dunrobin gold assets (the "JV Option"). In the event the JV Option is exercised, any such joint venture terminates upon the commencement of commercial gold production. In the event that Singa elects to exercise the JV option, Cradle Arc has the right to require Singa to exercise the Share Option. � An option fee of US$30,000 (the "Option Fee") is payable by Singa to Cradle Arc in three equal monthly tranches, commencing on the date of the Agreement. Kevin van Wouw, CEO of Cradle Arc, said: "The development of our Zambian gold assets has long been an important goal for the Company. We are, however, extremely mindful of the potential dilution that raising equity funds for the development of Matala could have on existing shareholders at the Company's current share price, and we therefore consider that this partnership with Singa represents the best path towards potential production in the near to mid-term. "Should the Share Option be exercised, the total amount payable to Cradle Arc would, in our view, represent fair value given the project's current stage of development and will support the Company's future strategy. On

A positive rns to me.

Exchanges are we listing on Mars or Jupiter?

breakeven by mid year looking very positive

Breakeven by mid year looking very poitive.

The potential for this company is outstanding and the placing will help its objectives so yes I believe it is way oversold.Are you a shareholder if so surely you understand that or why would you have bought in.If you are not a shraholde then goodbye.

too cheap now,way oversold.